[Type IIa dyslipoproteinemia. Effects of simvastatin and bezafibrate on atherogenic and non-atherogenic lipoprotein particles].
Lecerf
J M
JM
Bard
J M
JM
Leclerc
V
V
Douste-Blazy
P
P
Devulder
B
B
Harvengt
C
C
Fruchart
J C
JC
D001629:Bezafibrate / Q000494:pharmacology*; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood*; D006938:Hyperlipoproteinemia Type II / Q000097:blood*; D008074:Lipoproteins / Q000097:blood; D008148:Lovastatin / Q000031:analogs & derivatives* / Q000494:pharmacology; D019821:Simvastatin
D008074:Lipoproteins; D008148:Lovastatin; D019821:Simvastatin; D001629:Bezafibrate
Dyslipoprotéinémies de type IIa. Effets de la simvastatine et du bézafibrate sur les particules lipoprotéiques athérogènes et non athérogènes.